SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Office of Management and Budget Director Russell Vought talks to reporters outside the West Wing of the White House on June 3, 2025 in Washington, D.C.
(Photo: Anna Moneymaker/Getty Images)
'These People Should Not Be Managing a Lemonade Stand': Trump Admin Throws NIH Funding Into Chaos
The administration paused National Institutes of Health research funding before reversing course hours later amid fierce backlash.
Jul 30, 2025
The White House budget office, led by far-right ideologue and Project 2025 architect Russell Vought, temporarily halted National Institutes of Health funding for scientific research on Tuesday before announcing that the pause was lifted hours later, sparking further chaos and confusion at a key agency that's under growing attack from the administration.
The pause, which would have impacted roughly $15 billion in funding for research institutions across the United States, was implemented due to a footnote from Vought's office "in a document that doles out federal funds" to the NIH, according to The Wall Street Journal.
News of the pause, which applied to research grants and contracts, sparked immediate outrage, with Sen. Patty Murray (D-Wash.) warning it underscored the administration's plan to "decimate lifesaving research in this country."
But the Office of Management and Budget (OMB) appears to have reversed course. The Washington Post reported that the agency "releas[ed] the funds later in the day." The Health and Human Services Department, which oversees NIH, pointed to an OMB spokesperson's statement that "the funds were released" after a "programmatic review."
"The chaos and dysfunction of the Trump administration is staggering," Murray said Tuesday. "These people should not be managing a lemonade stand, much less all federal cancer research."
The White House has proposed slashing the NIH's budget by 40% next fiscal year. The nonpartisan Congressional Budget Office said earlier this month that the Trump administration's proposed cuts would "ultimately decrease the number of new drugs coming to market."
Tuesday's pause added to the turmoil at an agency that has already faced mass firings and attempts to slash critical funding.
Over the weekend, Vought described the NIH as "an agency that needs dramatic overhaul." Mother Jones reported earlier this year that the NIH "funded research that helped scientists better understand cystic fibrosis, which led to Vertex Pharmaceuticals developing a cutting-edge treatment" that Vought's daughter benefited from.
The Trump administration's effort to slash NIH funding "means that research into rare diseases, already inadequate, may slow down," the outlet noted.
"Ninety-five percent of rare diseases, unlike cystic fibrosis, have no treatment, according to the National Organization for Rare Disorders, and most organizations lack the budget to fund drug research in partnership with pharmaceutical companies," Mother Jones added.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
donald trumpoffice of management and budgetpublic healthrussell voughtwar on sciencenational institutes of health
The White House budget office, led by far-right ideologue and Project 2025 architect Russell Vought, temporarily halted National Institutes of Health funding for scientific research on Tuesday before announcing that the pause was lifted hours later, sparking further chaos and confusion at a key agency that's under growing attack from the administration.
The pause, which would have impacted roughly $15 billion in funding for research institutions across the United States, was implemented due to a footnote from Vought's office "in a document that doles out federal funds" to the NIH, according to The Wall Street Journal.
News of the pause, which applied to research grants and contracts, sparked immediate outrage, with Sen. Patty Murray (D-Wash.) warning it underscored the administration's plan to "decimate lifesaving research in this country."
But the Office of Management and Budget (OMB) appears to have reversed course. The Washington Post reported that the agency "releas[ed] the funds later in the day." The Health and Human Services Department, which oversees NIH, pointed to an OMB spokesperson's statement that "the funds were released" after a "programmatic review."
"The chaos and dysfunction of the Trump administration is staggering," Murray said Tuesday. "These people should not be managing a lemonade stand, much less all federal cancer research."
The White House has proposed slashing the NIH's budget by 40% next fiscal year. The nonpartisan Congressional Budget Office said earlier this month that the Trump administration's proposed cuts would "ultimately decrease the number of new drugs coming to market."
Tuesday's pause added to the turmoil at an agency that has already faced mass firings and attempts to slash critical funding.
Over the weekend, Vought described the NIH as "an agency that needs dramatic overhaul." Mother Jones reported earlier this year that the NIH "funded research that helped scientists better understand cystic fibrosis, which led to Vertex Pharmaceuticals developing a cutting-edge treatment" that Vought's daughter benefited from.
The Trump administration's effort to slash NIH funding "means that research into rare diseases, already inadequate, may slow down," the outlet noted.
"Ninety-five percent of rare diseases, unlike cystic fibrosis, have no treatment, according to the National Organization for Rare Disorders, and most organizations lack the budget to fund drug research in partnership with pharmaceutical companies," Mother Jones added.
The White House budget office, led by far-right ideologue and Project 2025 architect Russell Vought, temporarily halted National Institutes of Health funding for scientific research on Tuesday before announcing that the pause was lifted hours later, sparking further chaos and confusion at a key agency that's under growing attack from the administration.
The pause, which would have impacted roughly $15 billion in funding for research institutions across the United States, was implemented due to a footnote from Vought's office "in a document that doles out federal funds" to the NIH, according to The Wall Street Journal.
News of the pause, which applied to research grants and contracts, sparked immediate outrage, with Sen. Patty Murray (D-Wash.) warning it underscored the administration's plan to "decimate lifesaving research in this country."
But the Office of Management and Budget (OMB) appears to have reversed course. The Washington Post reported that the agency "releas[ed] the funds later in the day." The Health and Human Services Department, which oversees NIH, pointed to an OMB spokesperson's statement that "the funds were released" after a "programmatic review."
"The chaos and dysfunction of the Trump administration is staggering," Murray said Tuesday. "These people should not be managing a lemonade stand, much less all federal cancer research."
The White House has proposed slashing the NIH's budget by 40% next fiscal year. The nonpartisan Congressional Budget Office said earlier this month that the Trump administration's proposed cuts would "ultimately decrease the number of new drugs coming to market."
Tuesday's pause added to the turmoil at an agency that has already faced mass firings and attempts to slash critical funding.
Over the weekend, Vought described the NIH as "an agency that needs dramatic overhaul." Mother Jones reported earlier this year that the NIH "funded research that helped scientists better understand cystic fibrosis, which led to Vertex Pharmaceuticals developing a cutting-edge treatment" that Vought's daughter benefited from.
The Trump administration's effort to slash NIH funding "means that research into rare diseases, already inadequate, may slow down," the outlet noted.
"Ninety-five percent of rare diseases, unlike cystic fibrosis, have no treatment, according to the National Organization for Rare Disorders, and most organizations lack the budget to fund drug research in partnership with pharmaceutical companies," Mother Jones added.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.